Before and after using needles: how our patients views changed Much of the conversation around GLP-1 treatments focuses on the fear of needles before treatment begins
Here is where they differ: The dual-action mechanism of Mounjaro is the key reason it tends to produce stronger results
Acute Kidney Injury due to Volume Depletion Inform patients of the potential risk of acute kidney injury due to dehydration associated with gastrointestinal adverse reactions
At 36 weeks increases in heart rate relative to placebo were 2.1 (95% CI, 0.3 to 3.9), 2.3 (95% CI, 0.6 to 4.1), and 5.4 (95% CI, 3.6 to 7.1) beats per minute with tirzepatide 5, 10, and 15 mg, respectively, at week 36 compared to baseline
Gentle movement often helps
Cells were spun down at 100 rcf for 3 min and each single microwell contained at least 5000 cells, cultured in E8F medium (without antibiotic) containing 10 M ROCK inhibitor Y-27632 (10 mM stock, Stemcell Technologies, USA #72304)